A team of researchers at Heriot-Watt University have said they have shown 'extremely encouraging' results in their first ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative, patient-focused treatments, today responded to recent market rumors and inquiries from ...

COCP READ THE FULL COCP RESEARCH REPORT Business Update Phase 2a Trial of CC-42344 Extended On December 31, 2024, Cocrystal ...

Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...

Elderberry juice may be a potent tool for weight management and enhancing metabolic health, according to a recent Washington ...

Tran Le was an engineering student at Stanford University when she tried to enroll in a clinical trial for her chronic ...

Topline results from a phase 2/3 clinical trial showed that an eIF2B agonist to treat ALS failed to meet its primary endpoint ...

Clinical trials are underway in Colorado for a new drug that could extend a dog’s lifespan. Loyal, a San Francisco-based ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...

The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...